Erratum
for
Pisters and Le Chevalier, J Clin Oncol 23 (14) 3270-3278.
Journal of Clinical Oncology, Vol 26, No 13 (May 1), 2008: pp. 2238
© 2008 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2008.17.4037
ERRATUM
The May 10, 2005, review article by Pisters and Le Chevalier entitled, "Adjuvant Chemotherapy in Completely Resected Non–Small-Cell Lung Cancer" (J Clin Oncol 23:3270-3278, 2005) contained errors.
In the Discussion section, the last two sentences of the second to last paragraph gave the P values for cisplatin and UFT as 0.12 and 0.15 respectively, whereas it should have been .012 and .015, as follows:
"Cisplatin-based regimens (3,786 patients) showed a beneficial result with an HR of 0.891 (95% CI, 0.815 to 0.975; P = .012). Single-agent UFT therapy (1,751 patients) also showed a significant survival benefit, with an HR of 0.799 (95% CI, 0.668 to 0.957; P = .015)."
|
